Inventor · disambiguated record
Johann Karl
Also filed as: KARL JOHANN
40 granted patents·67 pending applications·256 citations·filing 1986–2024
97Inventor score
Files withROCHE DIAGNOSTICS OPERATIONS24ROCHE DIAGNOSTICS OPERATIONS INC21HOFFMANN LA ROCHE12KARL JOHANN9GENENTECH INC6
Top patents by PatentIndex Score
107 records- 0190US10557858B2Biomarkers for risk prediction of mortalityROCHE DIAGNOSTICS OPERATIONS INC·Filed 2017·Granted Feb 11, 2020·8 cites·23 claims
- 0287US11971407B2Detection of anti-p53 antibodiesROCHE DIAGNOSTICS OPERATIONS INC·Filed 2022·Granted Apr 30, 2024·1 cites·18 claims
- 0381US12306185B2Detection of anti-p53 antibodiesROCHE DIAGNOSTICS OPERATIONS INC·Filed 2024·Granted May 20, 2025·0 cites·16 claims
- 0481US5541117AImmunological method for the determination of a haemoglobin derivativeBOEHRINGER MANNHEIM GMBH·Filed 1993·Granted Jul 30, 1996·53 cites·13 claims
- 0579US7731938B2CYFRA 21-1 as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2007·Granted Jun 8, 2010·7 cites·3 claims
- 0678US8058013B2Assessing risk of disease progression in rheumatoid arthritis patientsKARL JOHANN·Filed 2009·Granted Nov 15, 2011·9 cites·2 claims
- 0776US11466098B2Binding agent and assay for PIVKAROCHE DIAGNOSTICS OPERATIONS INC·Filed 2020·Granted Oct 11, 2022·1 cites·14 claims
- 0875US9518990B2Secernin-1 as a marker for cancerWILD NORBERT·Filed 2011·Granted Dec 13, 2016·4 cites·4 claims
- 0975US8741587B2ARMET as a marker for cancerROESSLER MARKUS·Filed 2011·Granted Jun 3, 2014·3 cites·9 claims
- 1069US12351647B2Binding agent and assay for PIVKAROCHE DIAGNOSTICS OPERATIONS INC·Filed 2022·Granted Jul 8, 2025·0 cites·20 claims
- 1166US8980573B2Method for providing diagnosis of cancer using seprase as a markerROLLINGER WOLFGANG·Filed 2010·Granted Mar 17, 2015·2 cites·15 claims
- 1265US5627078AMultivalent dextran reagent for use in precipitation testsBOEHRINGER MANNHEIM GMBH·Filed 1994·Granted May 6, 1997·27 cites·10 claims
- 1364US2013171135A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1464US2013183300A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1564US2013243758A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1663US2013336960A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1763US2014017231A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1863US2014017232A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1963US2013336959A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2063US2014193397A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2163US2014056874A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 2263US2014056875A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 2363US2013344059A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 2463US2014023639A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 2562US11047866B2IGFBP7 for diagnosing diastolic dysfunctionROCHE DIAGNOSTICS OPERATIONS INC·Filed 2019·Granted Jun 29, 2021·0 cites·10 claims
- 2660US7205118B2Nicotinamide N-methyltransferase as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2005·Granted Apr 17, 2007·1 cites·3 claims
- 2760US6815217B2Use of check surfaces for identifying disturbing samples in a detection procedureROCHE DIAGNOSTICS GMBH·Filed 1998·Granted Nov 9, 2004·22 cites·34 claims
- 2860US2015072355A1Flap endonuclease-1 as a marker for cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2014·Application pending·0 cites
- 2960US2018364230A1DETECTION OF ANTI-p53 ANTIBODIESROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Application pending·0 cites
- 3058US2014056876A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3158US2015056642A1Armet as a marker for chronic obstructive pulmonary disease (copd)ROCHE DIAGNOSTICS OPERATIONS·Filed 2014·Application pending·0 cites
- 3258US2014023640A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3357US2014219998A1Armet as a marker for cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2014·Application pending·0 cites
- 3457US2013344060A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3556US6153393AElimination of interference in diagnostic methods by peptides comprising D-amino acidsROCHE DIAGNOSTICS GMBH·Filed 1998·Granted Nov 28, 2000·22 cites·26 claims
- 3656US5804450AMethod and reagent for the specific determination of LDL in serum samplesBOEHRINGER MANNHEIM GMBH·Filed 1996·Granted Sep 8, 1998·20 cites·14 claims
- 3756US4913179ADevice for washing off the inner surface of a reaction vessel and/or of the outer surface of a spheroidal reagent bodyBOEHRINGER MANNHEIM GMBH·Filed 1988·Granted Apr 3, 1990·39 cites·7 claims
- 3856US2016169895A1Flap endonuclease-1 as a marker for cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2016·Application pending·0 cites
- 3956US2015192587A1Use of protein s100a12 as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2014·Application pending·0 cites
- 4056US2016377625A1Armet as a marker for cancerROCHE DIAGNOSTICS OPERATIONS INC·Filed 2016·Application pending·0 cites
- 4155US2017115294A1Use of protein s100a12 as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS INC·Filed 2017·Application pending·0 cites
- 4254US11874282B2IGFBP-7 as a marker of preeclampsiaROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Granted Jan 16, 2024·0 cites·13 claims
- 4354US7785821B2Measurement of nicotinamde N-methyl transferase in diagnosis of lung cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2009·Granted Aug 31, 2010·0 cites·6 claims
- 4454US5631140AMethod for the quantitative determination of glycated proteinsBOEHRINGER MANNHEIM GMBH·Filed 1995·Granted May 20, 1997·20 cites·19 claims
- 4553US10345315B2IGFBP7 for diagnosing diastolic dysfunctionROCHE DIAGNOSTICS OPERATIONS INC·Filed 2016·Granted Jul 9, 2019·0 cites·10 claims
- 4653US2021132085A1Methods of identifying an individual as having or being at risk of developing an amyloid-positive dementia based on marker molecules and related usesGENENTECH INC·Filed 2021·Application pending·0 cites
- 4752US7981693B2Combined measurement of anti-CCP and serum amyloid A to assess rheumatoid arthritisROCHE DIAGNOSTICS OPERATIONS·Filed 2006·Granted Jul 19, 2011·0 cites·5 claims
- 4852US2021140971A1Prediction of preeclampsia based on igfbp-7ROCHE DIAGNOSTICS OPERATIONS INC·Filed 2021·Application pending·0 cites
- 4952US2016109461A1Fen1 as a marker for chronic obstructive pulmonary disease (copd)ROCHE DIAGNOSTICS OPERATIONS·Filed 2015·Application pending·0 cites
- 5052US2014341893A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerGENENTECH INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 107 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Johann Karl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →